Canasa
NDC Package 65084-474-14

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Canasa is mesalamine (also known as 5-aminosalicylic acid) is used to treat ulcerative proctitis, a type of bowel disease. Marketed by Mckesson Corporation Dba Rx Pak, this product is identified by NDC 65084-474 and is authorized under FDA application NDA021252.

Identification & Billing

NDC Package Code
65084-474-14
Package Description
30 SUPPOSITORY in 1 BOX
Product Code
65084-474
11-Digit Billing Format
65084047414

Clinical Specifications

Proprietary Name
Canasa
Dosage Form
-
Usage Information
Mesalamine (also known as 5-aminosalicylic acid) is used to treat ulcerative proctitis, a type of bowel disease. It does not cure ulcerative proctitis, but it may decrease the number of stools, the amount of mucus/blood in the stools, and the rectal bleeding caused by irritation/swelling of the colon/rectum. Mesalamine is an aminosalicylate anti-inflammatory drug. It is believed to work by blocking the production of certain natural chemicals that may cause pain and swelling.

Regulatory & Marketing

Labeler Name
Mckesson Corporation Dba Rx Pak
FDA Application #
NDA021252
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-05-2001
End Marketing Date
09-01-2019
Listing Expiration
09-01-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65084-474-14 identifies a specific commercial package of 30 suppository in 1 box of Canasa, labeled by Mckesson Corporation Dba Rx Pak. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mckesson Corporation Dba Rx Pak on January 05, 2001. The current certification is valid through September 01, 2019.

What are the primary indications for this medication?

Mesalamine (also known as 5-aminosalicylic acid) is used to treat ulcerative proctitis, a type of bowel disease. It does not cure ulcerative proctitis, but it may decrease the number of stools, the amount of mucus/blood in the stools, and the rectal bleeding caused by irritation/swelling of the colon/rectum. Mesalamine is an aminosalicylate anti-inflammatory drug. It is believed to work by blocking the production of certain natural chemicals that may cause pain and swelling.

How is this Mckesson Corporation Dba Rx Pak product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65084047414. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65084-474-14
11-Digit CMS (5-4-2)
65084-0474-14

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.